euroendocrine consequences of sleep-disturbances in type 2 diabetes patients with and without depressio

Completed

• Conditions: Insomnia Diabetes Depression; 10018424; 10027946

• Registration Number: NL-OMON37594
• Lead Sponsor: Vrije Universiteit Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 220

Inclusion Criteria

Confirmed type-2-diabetes, 18- years and over

Exclusion Criteria

Severe substance abuse or dependence, severe language barrier, psychosis, acute suicidality

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>HbA1C</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>n.a.</p><br>